Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
34.41
+0.49 (1.44%)
At close: Dec 5, 2025, 4:00 PM EST
34.40
-0.01 (-0.03%)
After-hours: Dec 5, 2025, 6:28 PM EST
Liquidia Revenue
Liquidia had revenue of $54.34M in the quarter ending September 30, 2025, with 1,121.72% growth. This brings the company's revenue in the last twelve months to $69.22M, up 343.41% year-over-year. In the year 2024, Liquidia had annual revenue of $14.00M, down -19.97%.
Revenue (ttm)
$69.22M
Revenue Growth
+343.41%
P/S Ratio
42.48
Revenue / Employee
$407,153
Employees
170
Market Cap
2.99B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LQDA News
- 17 days ago - Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 18 days ago - This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - The Motley Fool
- 4 weeks ago - Liquidia Corporation: Heading In The Right Direction - Seeking Alpha
- 4 weeks ago - Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences - GlobeNewsWire
- 5 weeks ago - Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript - Seeking Alpha
- 5 weeks ago - Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 2 months ago - Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 - GlobeNewsWire